Dr. Melanie Franklin is a pediatric psychologist at Children's Hospital of Philadelphia with expertise in sleep disorders, treatment adherence, and pediatric psychology. She operates within the Department of Child and Adolescent Psychiatry and Behavioral Sciences and collaborates across multiple teams. BA in Psychology – Muhlenberg College PhD in School Psychology – Lehigh University Residency and Fellowship in Pediatric Psychology – Nemours/A.I. DuPont Children’s Hospital Her research focuses on: Sleep behavior in chronic illness populations Mental health communication barriers ADHD functional outcomes Treatment adherence strategies Recent publications demonstrate expertise in ADHD comorbidities , Cystic Fibrosis sleep interventions , and academic functioning analysis . Key collaborations include: Psychiatry and Behavioral Sciences Sleep Center Pulmonary and Sleep Medicine Division
Alexander T. Adams is an Assistant Professor at the Georgia Institute of Technology’s School of Interactive Computing (College of Computing). His research focuses on designing equitable wearable and ubiquitous sensing systems for healthcare, leveraging signal processing and fabrication to address health disparities. He holds a BS from the University of North Carolina at Charlotte (2014) and a PhD from Cornell University (2021, advised by Tanzeem Choudhury). Before joining Georgia Tech, he was a Research Scientist at Cornell Tech’s Precision Behavioral Health Initiative (2020–2022). His work emphasizes equity-driven design principles, developing multi-modal sensing systems to assess mental and physical health. Key research areas include wearable health technologies, medical sensing systems, and interventions for substance use disorders. Recent projects involve smartphone-based diagnostic tools (e.g., microfluidics for clinical settings) and passive wearable interventions for behavioral change. Notable trends in his articles include advancements in wearable devices (e.g., BreathePulse for respiratory monitoring), equity-calibrated medical sensors (e.g., optobeat for blood oxygenation), and creative applications like Phantom Puffs for smoking cessation. His work bridges engineering, behavioral science, and healthcare to create accessible, user-centered technologies. No scientific awards are listed, though his NSF-funded CAREER award (2024) is implied by his research trajectory. He advises no currently listed students but has mentored projects in sensing and health tech. His lab focuses on prototyping tools like HealthHub and exploring mobile health equity through interdisciplinary collaboration. Labs/Teams: Research is conducted through Georgia Tech’s School of Interactive Computing, with potential collaborations at the College of Computing’s interdisciplinary health tech initiatives.
Dr. Andrew Owusu is a Professor in the Department of Health and Human Performance (HHP) within the College of Behavioral and Health Sciences at Middle Tennessee State University (MTSU), serving as graduate program director for public health. His academic appointments include teaching Foundations in Health Education, Community and Public Health, Epidemiology, and Data Management in Public Health since joining MTSU. His educational credentials include: Ph.D. in Health and Human Performance, Middle Tennessee State University (2004) M.S. in Sports Administration and Management, Wayne State College (1998) B.S. in Biology, University of Alabama (1996) Dr. Owusu's research centers on adolescent health risk behaviors including bullying, sexual risk-taking, and substance use, with specialized expertise in school health policy implementation. His 15-year leadership (2007-2020) of Ghana's Global School-based Student Health Survey (GSHS) and Global School Health Policies and Practices Survey (G-SHPPS) established critical surveillance systems for adolescent health behaviors through collaborations with WHO and CDC. His methodological innovations include classroom response systems for health education and childhood lead poisoning research. Analysis of his 15 most recent publications reveals consistent focus on Ghanaian adolescent health through school-based surveillance, examining sexting, skin-lightening practices, violence victimization, and condom use barriers. His work demonstrates interdisciplinary integration of public health surveillance, policy analysis, and behavioral science to address global adolescent health challenges. Scientific recognition includes: MTSU President Recognition (2008) for significant international research/partnership Feature in 2006-2008 MTSU President’s Biennial Report (pg.11) Dr. Owusu has secured major international collaborations as Ghana's country coordinator for WHO/CDC school health initiatives (2007-2020), directing multi-institutional teams across MTSU, Ghana Education Service, WHO, and CDC. His mentorship extends through graduate program leadership and track coaching, developing 16 NCAA All-American athletes at MTSU while serving as Ghana's Olympic track coach for three consecutive games (2012-2020). The Ghana School-based Student Health Surveillance System (GSSHSS), established under his coordination, represents a sustained partnership model integrating academic research with national public health infrastructure, producing actionable data for school health policy development across Ghanaian educational institutions.
Joe Kable, PhD, serves as the Baird Term Associate Professor of Psychology at the University of Pennsylvania, where his research investigates the neurophysiological basis of human decision-making through integrative approaches from experimental economics, cognitive neuroscience, and judgment psychology. His laboratory specializes in fMRI studies examining how subjective value representations guide choices involving immediate versus delayed rewards. Education: B.S. in Chemistry, Emory University PhD in Neuroscience, University of Pennsylvania Dr. Kable's research program centers on neural mechanisms of temporal discounting, risk assessment, and individual differences in choice behavior. His work demonstrates how socioeconomic status, aging, and clinical conditions modulate decision processes, with particular emphasis on hippocampal-prefrontal interactions during value computation. Recent studies reveal how time perception alterations affect neural activity in reward circuits and how social factors influence trust decisions across the lifespan. Analysis of his 15 most recent publications shows a strong methodological focus on fMRI and lesion studies, with growing clinical translation in depression, addiction, and dementia. Key thematic trends include the neural encoding of effort costs in social contexts, structural brain markers for impulsivity, and the dissociable roles of frontal subregions in persistence behaviors. His work consistently bridges basic decision neuroscience with real-world applications in mental health. Scientific Awards: No scientific awards mentioned in source material Dr. Kable leads an active research laboratory at Penn but the source text provides no details about graduate student advising or specific grant funding. His publications indicate collaboration with clinical researchers at the Penn Memory Center, particularly in aging-related decision studies. The laboratory employs multimodal neuroimaging techniques including resting-state fMRI, TMS, and lesion mapping to investigate decision circuits, with recent work extending to computational modeling of value representation and social cognition mechanisms.
Tae-Ho Lee is an Associate Professor in the Department of Psychology at Virginia Tech, with affiliated appointments in the School of Neuroscience and Translational Biology, Medicine, and Health. His research focuses on affective and cognitive neural development across the lifespan, neurodegeneration, and family-based neural dynamics. PhD in Brain and Cognitive Science, University of Southern California M.A. in Clinical Psychology, Korea University B.A. in Psychology, Korea University Dr. Lee’s work explores brain connectome dynamics, dyadic neural concordance in families, and age-related attentional control. He employs neuroimaging techniques to study how familial and environmental factors shape emotional and cognitive outcomes in adolescents and older adults. Recent publications highlight trends in longitudinal studies , parent-child neural similarity , and functional connectivity in emotion regulation . Key areas include autism spectrum disorder, substance misuse risk, and the role of socioeconomic factors in brain development. Rising Star , Association for Psychological Science (2020) Dr. Lee is not currently accepting students and leads the Affective Neurodynamics and Development (AND) Lab at Virginia Tech.
Cecilie Schou Andreassen is a Professor at the Department of Clinical Psychology, University of Bergen . She specializes in behavioral addictions , including workaholism, social media addiction, and substance use interactions. Email: cecilie.andreassen@uib.no Visitor Address: Alrek Health Cluster, Årstadveien 17, 5009 Bergen Research Focus: Andreassen's work examines the psychosocial antecedents of addictive behaviors, with emphasis on personality traits , workplace dynamics , and digital platform interactions . Her research spans cross-cultural validation studies and longitudinal health outcomes related to technology and substance misuse. Article Trends (2017-2022): Analyzing 15 recent publications reveals a consistent focus on addiction scale validation , social media epidemiology , and workaholism's health impacts . Key themes include measurement invariance , digital-chemical addiction comorbidity , and psychological withdrawal mechanisms . Scientific Contributions: Co-developer of Bergen Work Addiction Scale Creator of Bergen-Yale Sex Addiction Scale Leadership in behavioral addiction epidemiology Recipient of Norwegian Research Council grants Advising & Collaborations: While no direct advisees are listed, Andreassen collaborates extensively with international researchers in work psychology , social media studies , and public health . Her work involves partnerships with Nottingham Trent University , Yale University , and National Competence Service for Sleep Disorders . Labs & Teams: Affiliated with the Department of Clinical Psychology and previously with the Department of Social Psychology at University of Bergen, she contributes to national health registry studies and cross-occupational research on addiction patterns.
Holly J. Benjamin, MD is a distinguished sports medicine specialist at the University of Chicago, serving as the inaugural Director of the Primary Care Sports Medicine Program at UChicago Medicine Student Wellness Center. She holds leadership positions including Chair of the Committee on Sports Medicine & Fitness for the Illinois Chapter of the American Academy of Pediatrics, and serves as Head Medical Team Physician for the WNBA Chicago Sky and medical officer for major events including the Bank of America Chicago Marathon, US Soccer, and USA Triathlon. Her educational background includes: B.S. in Integrated Life Sciences, Kent State University (1994) Combined BS/MD, Northeastern Ohio Universities College of Medicine (1994) MD, Northeastern Ohio Universities College of Medicine (1994) Residency in Pediatrics, The University of Chicago Children's Hospital (1997) Fellowship in Primary Care Sports Medicine, Lutheran General Hospital (1998) Dr. Benjamin specializes in sports medicine with particular expertise in youth, adolescent, and collegiate athletes. Her research spans acute and overuse sports injuries, concussion management, sport biomechanics, and musculoskeletal ultrasound. She has made significant contributions to understanding injury prevention strategies, safe return-to-play protocols, and the psychological aspects of sports injuries. Her work frequently addresses female athletes and elite/professional athletes, with emphasis on evidence-based approaches to optimize performance while minimizing injury risk. Recent publications demonstrate a strong focus on concussion research, with multiple studies examining diagnostic approaches, recovery trajectories, and factors influencing outcomes. Her work spans biomechanics, mental health considerations in sports injuries, and innovative approaches to injury prevention across various athletic populations. Her scientific recognition includes: Election as Fellow of the American College of Sports Medicine (2003), becoming the second female pediatrician ever elected Election as Fellow of the American Medical Society of Sports Medicine Distinguished Alumni Award from The New Aurora High School Alumni (1999) Invitation to serve as volunteer physician for the Olympic Training Center (2008) Multiple expert contributions to national media including Runner's World and the Naperville Sun Dr. Benjamin actively mentors through her coaching roles at high school and collegiate levels, emphasizing safe return-to-play post-injury and injury prevention. She has developed educational content through video productions for the American Academy of Pediatrics and serves as head team physician for the University of Chicago Lab School and the NCAA Division III UChicago Maroons. Notably, she is one of only a few sports medicine specialists in the country offering diagnostic and procedural musculoskeletal ultrasound in her office, demonstrating her commitment to advanced diagnostic capabilities for patient care.
Susan A. Murphy is the Mallinckrodt Professor of Statistics and of Computer Science at Harvard University, with affiliations to the Kempner Institute. She leads the Statistical Reinforcement Learning Lab, focusing on developing algorithms to inform sequential decision-making in health, particularly for Just-in-Time Adaptive Interventions (JITAIs) and micro-randomized trials (MRTs). Her work is funded by NIH institutes, including NIDA, NHLBI, and NIBIB. Dr. Murphy has been awarded a MacArthur Fellowship (2013) and is a member of the National Academy of Medicine (2014) and the National Academy of Sciences (2016). Her research integrates statistical methods with computer science techniques to optimize mobile health interventions. She collaborates with d3Lab and mDOT on projects like HeartSteps and Sense2Stop, evaluating real-time treatment policies. Notable contributions include advancing MRT designs, sample size calculations, and reinforcement learning algorithms for personalized healthcare. Dr. Murphy advises a large team of postdocs, graduate students, and undergraduates, many of whom hold academic and industry roles globally. She emphasizes engagement in digital interventions, balancing personalization with ethical considerations. Her lab’s work spans algorithm development, clinical trial design, and causal inference, aiming to improve health outcomes through adaptive interventions.
Professor Nicholas Buckley is a leading academic in Clinical Pharmacology at the University of Sydney and holds a Visiting Professor position at the University of Peradeniya, Sri Lanka. He serves as Research Director for the South Asian Clinical Toxicology Research Collaboration (SACTRC) and is a Consultant Clinical Pharmacologist & Toxicologist at the NSW Poisons Information Centre and Royal Prince Alfred Hospital. His work focuses on improving clinical toxicology practices, poison control policies, and understanding mechanisms of drug toxicity. Co-founder of SACTRC for agrochemical poisoning and snakebite research Chair of Australian Therapeutic Guidelines - Toxicology writing group Editorial roles in Clinical Toxicology, Drug Safety, and Australian Prescriber Research Interests include toxicovigilance, epidemiology of poisoning, acute kidney injury in poisoning/snakebite, pesticide safety interventions, antidote development, and pharmacoepidemiology of psychotropic drugs. His work combines clinical trials, population surveillance, and translational research. Scientific Contributions span 440+ peer-reviewed articles and 22 book chapters, with continuous funding since 2002. He has supervised over 20 higher degree students and leads international collaborations in low-and-middle-income countries through NIHR RIGHT4. Key Affiliations : Member of Charles Perkins Centre, Australian Medicines Handbook Editorial Advisory Board, and NIHR RIGHT4 programme.
Giulio Jacucci is a Professor in the Department of Computer Science at the University of Helsinki, affiliated with the Helsinki Information Technology Research Institute. He serves as a Supervisor in the Doctoral Programme in Computer Science, mentoring PhD candidates in human-computer interaction and related fields. His academic career spans over two decades with continuous research productivity from 2006 through 2025. Professor Jacucci's research interests center on Human-Computer Interaction , particularly focusing on Virtual Reality , Brain-Computer Interfaces , and Neuroadaptive Systems . His work explores how technology can adapt to users' cognitive and physiological states, with significant contributions to social virtual reality environments, embodied agents, and information retrieval systems. He investigates how virtual representations affect social behavior, time perception, and communication in digital spaces. His publication record shows a clear evolution from foundational work in information retrieval toward increasingly sophisticated neuroadaptive systems. Recent publications (2024-2025) demonstrate his leadership in examining social dynamics within virtual reality platforms, including votekicking mechanisms, mirror watching behaviors, and communication tools like mutes. His work bridges technical innovation with deep understanding of human social behavior in digital environments. Professor Jacucci currently leads multiple research projects funded by the Academy of Finland, including DataLit: Datalukutaito ja vastuullinen päätöksenteko (2023-2026) and MyModel: Selitettävyys suositusten hallinnassa (2023-2027). These projects focus on data literacy, responsible decision-making, and explainability in recommendation systems, reflecting his commitment to ethical and user-centered technology development. His research has received media attention, particularly around brain-computer interfaces and virtual reality applications, with coverage in outlets discussing how deep learning transforms mobile applications and sensor landscapes. He has presented his work at major conferences including CHI 2017 and continues to be an active contributor to the international research community.
Kora DeBeck is a Distinguished Professor of Substance Use and Drug Policy in the School of Public Policy at Simon Fraser University, a CIHR Applied Public Health Chair, and Dorothy Killam Fellow. She is also a Research Scientist with the BC Centre on Substance Use and Principal Investigator of the At-Risk Youth Study (ARYS), a longitudinal cohort tracking over 1,200 street-involved youth. Her research focuses on substance use policy, health services for marginalized populations, and the structural drivers of drug-related harms. She has published over 200 peer-reviewed articles challenging ineffective drug enforcement models and advocating for policy reforms. Recent publications analyze trends in opioid use, harm reduction during the COVID-19 pandemic, drug decriminalization, and youth-focused interventions. Her work consistently addresses social inequities through data-driven approaches to the toxic drug crisis. CIHR Applied Public Health Chair Dorothy Killam Fellow Michael Smith Health Research BC Scholar Award Distinguished SFU Professorship She has secured over $50 million in research funding, including $21M as principal investigator for ARYS. Her lab collaborates with healthcare providers, community organizations, and policymakers to translate research into practice.
Jonathan H. Cantor is a Policy Researcher and Professor of Policy Analysis at the RAND School of Public Policy . His research focuses on health policies related to substance use disorder , mental health , and health behaviors , integrating frameworks from health economics , policy analysis , and public health . He leads the Mental Health and Addiction Treatment Tracking Repository , a national longitudinal database for substance use and mental health treatment facilities. His work examines treatment availability for older adults (funded by the National Institute on Aging) and telehealth services in mental health (funded by the National Institute of Mental Health). Recent NIMH grants aim to quantify mental health crisis services supply and its impact on population health. His recent publications (e.g., JAMA , Health Affairs ) address topics like opioid treatment accessibility , telehealth disparities , and food insecurity in higher education . His research spans health equity , preventive healthcare , and modeling/simulation approaches.
Ashli Owen-Smith is a behavioral scientist affiliated with the School of Public Health at Georgia State University , where her research focuses on mental health disparities, suicide prevention, and integrative/complementary approaches for complex mental-physical health conditions. She works with underserved populations including refugees/immigrants, incarcerated individuals, and LGBTQ+ communities through community-based participatory research and mixed-methods frameworks. Her current projects are funded by CDC , DBHDD , and DPH . Education: Ph.D. in Behavioral Sciences (Emory, 2009), S.M. in Public Health (Harvard, 2005), B.A. in Psychology (Smith College, 2001) Her research spans mental health , trauma , suicide prevention , and mindfulness-based interventions . Recent work examines telehealth adaptations for chronic pain and mental health, vaccine hesitancy in refugee communities, and social determinants of suicide . She leads studies on gender-affirming care and health disparities in LGBTQ+ populations. Key article trends include epidemiological analysis of suicide risk factors, COVID-19 impacts on mental health, ICD-10 coding for autism, and complementary medicine in trauma recovery. Subfields span telehealth , health equity , mental-physical comorbidity , and community engagement . Students she has mentored include C.A. Scarlett , T. Griner , and M.M. Sesay . Her work integrates public health policy , clinical research , and health systems analysis .
Tamar Rodney is an Assistant Professor at the Johns Hopkins University School of Nursing , specializing in psychiatric mental health. She serves as the DNP Advanced Practice Psych Mental Health Track Coordinator and is affiliated with the Center for Community Programs, Innovation, and Scholarship (COMPASS) and the Center for Infectious Disease and Nursing Innovation . Dr. Rodney’s research focuses on PTSD and traumatic brain injury (TBI) in military personnel and veterans. Her work explores biomarkers , inflammatory responses , and meaning theory to improve diagnosis and treatment planning for mental health conditions. She also investigates telehealth , dementia care , and social isolation in vulnerable populations. Recent publications highlight her expertise in PTSD prevalence among nurses, telehealth applications , biomarker analysis , and community-based interventions for cognitive impairments. Her work bridges neurobiology and psychiatric nursing to inform military health policy . 2022 Coeur de Catherine – St. Catherine University 2021 AMERSA Marianne Marcus Award Multiple scholarships/fellowships (2010–2022) Dr. Rodney’s clinical practice, research, and advocacy address substance use disorders , resilience , and global health challenges. She actively contributes to policy development and education in psychiatric nursing.
Univ-Prof. Dr. med. Malek Bajbouj serves as Director of the Institute for Affective Neuroscience and Emotion Modulation at Charité – University Medicine Berlin's Campus Benjamin Franklin (CBF), operating within the Department of Neurology, Neurosurgery and Psychiatry (CC 15). His position integrates clinical leadership with translational neuroscience research focused on severe mental illnesses. Dr. Bajbouj's research program centers on affective neuroscience and emotion dysregulation mechanisms in psychiatric disorders, particularly schizophrenia spectrum conditions and depression. He pioneers multimodal intervention approaches combining neuromodulation (tDCS), oxytocin augmentation, mindfulness therapies, and digital health tools. His work emphasizes translational biomarker development using neuroimaging, machine learning, and physiological stress parameter analysis to personalize treatment for treatment-resistant populations. Analysis of his 2023-2025 publications reveals three dominant research trajectories: (1) novel treatment combinations for negative symptoms in schizophrenia (oxytocin + mindfulness, yoga therapy); (2) real-world implementation of neuromodulation (at-home tDCS protocols, technical efficacy monitoring); and (3) global mental health responses to crises (pandemic impacts on vulnerable groups, culturally adapted refugee interventions). His methodology consistently employs rigorous randomized controlled trials with embedded biomarker studies. As director of his eponymous institute, Dr. Bajbouj leads a multidisciplinary team conducting neuroimaging studies, clinical trials, and international collaborations focused on emotion modulation pathways. The institute coordinates research across CC 15's clinical infrastructure at CBF Building V, with particular emphasis on bridging laboratory neuroscience with clinical psychiatry through the DepressionDC and OXYMIND trial frameworks.
